RNAC vs STE · P/E 2.1, rev $38.9M vs P/E 25, rev $5.46B
Cartesian Therapeutics Inc. (RNAC) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
RNAC currently screens at market cap $290.9M and trailing P/E 2.1. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the RNAC and STE stock pages for the full models.
Not investment advice.